Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
These resolutions triggered mandatory cessation of compounding after grace periods60 days for 503A pharmacies, 90 days for 503B facilities
Research market participation creates ambiguous rather than clear legal risk
Regulators see untested drugs requiring restriction until proven safe
Usage Safety: Protect from sharp temperature shifts post-reconstitution and avoid multiple freeze-thaw cycles to keep the setup stable
(2025, December)
US$ 25.77
US$ 24.90
US$ 21.91
US$ 24.92
US$ 24.93
